Baroness Louise Casey blasted the NHS medicines regulator NICE for rejecting a new ‘expensive’ Alzheimer’s drug
Notifications can be managed in browser preferences.
Swipe for next article
Baroness Louise Casey blasted the NHS medicines regulator NICE for rejecting a new ‘expensive’ Alzheimer’s drug
Removed from bookmarks
I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
It’s being called a ‘backward step for NHS care’
The high costs, due to high demand and an under-supplied market, has been labelled a ‘market failure’
NHS is set to remove more than 280 patients from St Andrew’s Healthcare in Northampton
Those in end-of-life care facing ‘postcode lottery,’ a report from MPs says
Two breakthrough Alzheimer's drugs cost too much and have too little benefit for NHS use, review finds.
Sanofi’s market access chief urges ministers to come up with a roadmap to raise spending on new treatments
